Gabapentin can be habit forming, but the risk depends heavily on your personal history. For most people taking it as prescribed for nerve pain or seizures, gabapentin has limited addictive potential. The group most likely to develop a problematic habit consists of people with a current or past history of substance use, particularly those who use opioids or multiple drugs. A systematic review found only four documented cases of behavioral dependence in patients who had no prior history of substance misuse.
How Gabapentin Works in the Brain
Despite its name resembling GABA (a calming brain chemical), gabapentin doesn’t actually bind to GABA receptors. It also doesn’t latch onto the receptors targeted by benzodiazepines, opioids, or cannabis. Instead, it binds to a specific part of voltage-dependent calcium channels in the brain, which dampens nerve signaling. This is why it helps with seizures and nerve pain.
Gabapentin does increase GABA levels and decrease glutamate (an excitatory chemical) in the brain, which produces its calming effects. Whether it activates the brain’s dopamine reward pathway, the system responsible for the “high” that drives classic addiction, remains unclear. This may explain why its addictive pull is weaker than drugs like opioids or benzodiazepines, which directly flood reward circuits.
Physical Dependence vs. Addiction
This distinction matters. Physical dependence means your body adapts to the drug and reacts when you stop taking it. Addiction involves compulsive drug-seeking behavior despite harmful consequences. Gabapentin can cause both, but physical dependence is far more common.
Many people who take gabapentin daily for weeks or months will experience withdrawal symptoms if they stop abruptly. That doesn’t mean they’re addicted. It means their nervous system adjusted to the drug’s presence and needs time to recalibrate. True addiction to gabapentin, characterized by taking escalating doses, obtaining extra prescriptions, or using it to get high, appears concentrated among people with prior substance use histories. In one review, every documented case of gabapentin addiction involved a patient with a history of alcohol, cocaine, or opioid misuse, and those patients were typically taking more than 3,000 mg per day (well above standard doses).
Who Is Most at Risk
The clearest risk factor is a history of substance use disorder. Surveys have found that gabapentin misuse runs about 1.1% in the general population but jumps to 22% among people in drug abuse treatment programs. Between 15% and 22% of people who misuse opioids also report misusing gabapentin, often because it can intensify the effects of opioids or ease withdrawal symptoms between doses.
In one study tracking drug use in rural Appalachia, nonmedical gabapentin use went from 0% in 2008 to 56% by 2020. That dramatic rise was driven by people already using other substances. The combination is dangerous: gabapentin-related overdose deaths nearly tripled over a similar period, and most of those deaths involved opioids, particularly fentanyl.
Withdrawal Symptoms
Stopping gabapentin suddenly after regular use can trigger withdrawal symptoms within 12 hours to 7 days. Most cases resolve within 5 to 10 days, though some people need up to 18 weeks to fully taper off while managing symptoms.
Common withdrawal symptoms include:
- Anxiety, restlessness, and agitation
- Insomnia
- Excessive sweating
- Nausea and stomach pain
- Headaches and dizziness
- Confusion or disorientation
Less common but more serious symptoms can include seizures, heart palpitations, high blood pressure, depressed mood, and suicidal thoughts. Seizures are a particular concern for people who were taking gabapentin for epilepsy, since stopping abruptly can lower their seizure threshold below where it was before they started the medication.
How to Stop Safely
Gabapentin should be tapered gradually rather than stopped cold. Clinical guidelines suggest reducing your dose by 5 to 10% every two to six weeks, with no single weekly reduction exceeding 300 mg. Some people tolerate faster tapers (up to 25% per step), while others need a slower approach.
An important detail: as your total dose gets lower, the amount you cut each step should shrink proportionally. At 3,600 mg daily, a 10% cut means dropping 360 mg. At 1,200 mg daily, 10% is only 120 mg. Cutting the same fixed amount at every step makes the final reductions too steep relative to what’s left. Keeping a symptom diary during the taper helps you and your prescriber decide when to hold steady at a dose before making the next reduction.
How Gabapentin Compares to Pregabalin
Pregabalin (Lyrica) belongs to the same drug class and works through a similar mechanism, but it carries a higher risk of misuse. Pregabalin is classified as a Schedule V controlled substance federally, while gabapentin is not scheduled at the federal level. The difference comes down to pregabalin being absorbed more predictably and producing more noticeable mood effects, which makes it more appealing to people seeking a high. Research confirms that pregabalin shows stronger behavioral dependence symptoms, more transitions from prescribed use to self-administration, and longer patterns of misuse than gabapentin. Overdoses involving pregabalin alone are also more dangerous.
Legal Status and Growing Concern
Gabapentin is not a federally controlled substance under the Controlled Substances Act. However, several states have taken independent action. Kentucky became the first state to classify gabapentin as a Schedule V controlled substance in 2017, after data showed it was involved in more than one-third of overdose deaths between 2013 and 2015. Other states have followed with various monitoring requirements.
The FDA has issued safety warnings about serious breathing problems in patients using gabapentin, particularly those who also take opioids, benzodiazepines, or other sedating drugs, and those with lung conditions like COPD. The FDA also specifically flagged the rising trend of co-use with opioids, noting it increases the risk of respiratory depression. Warning signs of this dangerous interaction include extreme sleepiness, slowed or shallow breathing, confusion, and bluish discoloration of the lips or fingertips.
The Bottom Line on Habit Formation
Gabapentin occupies a middle ground. It is not as aggressively habit forming as opioids, benzodiazepines, or even its close relative pregabalin. But calling it non-addictive, as was common when it first gained popularity, understates the real risks. Your body can become physically dependent on it with regular use, withdrawal can be significant, and for people with a history of substance use, the potential for genuine addiction is well documented. The safest approach is to take it only as prescribed, never stop abruptly, and be straightforward with your prescriber about any history of substance use.